Previously, image interpretation in radiology relied heavily on manual methods. However, manual classification of brain tumor medical images is time-consuming and labor-intensive. Even with shallow convolutional neural network models, the accuracy is not ideal. To improve the efficiency and accuracy of brain tumor image classification, this paper proposes a brain tumor classification model based on an improved ResNet34 network. This model uses the ResNet34 residual network as the backbone network and incorporates multi-scale feature extraction. It uses a multi-scale input module as the first layer of the ResNet34 network and an Inception v2 module as the residual downsampling layer. Furthermore, a channel attention mechanism module assigns different weights to different channels of the image from a channel domain perspective, obtaining more important feature information. The results after a five-fold crossover experiment show that the average classification accuracy of the improved network model is approximately 98.8%, which is not only 1% higher than ResNet34, but also only 80% of the number of parameters of the original model. Therefore, the improved network model not only improves accuracy but also reduces clutter, achieving a classification effect with fewer parameters and higher accuracy.

The early and accurate classification of brain tumors is crucial for guiding effective treatment strategies and improving patient outcomes. This study presents BrainFusion, a significant advancement in brain tumor analysis using magnetic resonance imaging (MRI) by combining fine-tuned convolutional neural networks (CNNs) for tumor classification--including VGG16, ResNet50, and Xception--with YOLOv8 for precise tumor localization with bounding boxes. Leveraging the Brain Tumor MRI Dataset, our experiments reveal that the fine-tuned VGG16 model achieves test accuracy of 99.86%, substantially exceeding previous benchmarks. Beyond setting a new accuracy standard, the integration of bounding-box localization and explainable AI techniques further enhances both the clinical interpretability and trustworthiness of the system's outputs. Overall, this approach underscores the transformative potential of deep learning in delivering faster, more reliable diagnoses, ultimately contributing to improved patient care and survival rates.

Brain tumors are serious health problems that require early diagnosis due to their high mortality rates. Diagnosing tumors by examining Magnetic Resonance Imaging (MRI) images is a process that requires expertise and is prone to error. Therefore, the need for automated diagnosis systems is increasing day by day. In this context, a robust and explainable Deep Learning (DL) model for the classification of brain tumors is proposed. In this study, a publicly available Figshare dataset containing 3,064 T1-weighted contrast-enhanced brain MRI images of three tumor types was used. First, the classification performance of nine well-known CNN architectures was evaluated to determine the most effective backbone. Among these, EfficientNetV2 demonstrated the best performance and was selected as the backbone for further development. Subsequently, an attention-based MLP-Mixer architecture was integrated into EfficientNetV2 to enhance its classification capability. The performance of the final model was comprehensively compared with basic CNNs and the methods in the literature. Additionally, Grad-CAM visualization was used to interpret and validate the decision-making process of the proposed model. The proposed model's performance was evaluated using the five-fold cross-validation method. The proposed model demonstrated superior performance with 99.50% accuracy, 99.47% precision, 99.52% recall and 99.49% F1 score. The results obtained show that the model outperforms the studies in the literature. Moreover, Grad-CAM visualizations demonstrate that the model effectively focuses on relevant regions of MRI images, thus improving interpretability and clinical reliability. A robust deep learning model for clinical decision support systems has been obtained by combining EfficientNetV2 and attention-based MLP-Mixer, providing high accuracy and interpretability in brain tumor classification.

Brain tumors show significant health challenges due to their potential to cause critical neurological functions. Early and accurate diagnosis is crucial for effective treatment. In this research, we propose ResLink, a novel deep learning architecture for brain tumor classification using CT scan images. ResLink integrates novel area attention mechanisms with residual connections to enhance feature learning and spatial understanding for spatially rich image classification tasks. The model employs a multi-stage convolutional pipeline, incorporating dropout, regularization, and downsampling, followed by a final attention-based refinement for classification. Trained on a balanced dataset, ResLink achieves a high accuracy of 95% and demonstrates strong generalizability. This research demonstrates the potential of ResLink in improving brain tumor classification, offering a robust and efficient technique for medical imaging applications.

Clinical cystoscopy, the current standard for bladder cancer diagnosis, suffers from significant reliance on physician expertise, leading to variability and subjectivity in diagnostic outcomes. There is an urgent need for objective, accurate, and efficient computational approaches to improve bladder cancer diagnostics. Leveraging recent advancements in deep learning, this study proposes an integrated multi-task deep learning framework specifically designed for bladder cancer diagnosis from cystoscopic images. Our framework includes a robust classification model using EfficientNet-B0 enhanced with Convolutional Block Attention Module (CBAM), an advanced segmentation model based on ResNet34-UNet++ architecture with self-attention mechanisms and attention gating, and molecular subtyping using ConvNeXt-Tiny to classify molecular markers such as HER-2 and Ki-67. Additionally, we introduce a Gradio-based online diagnostic platform integrating all developed models, providing intuitive features including multi-format image uploads, bilingual interfaces, and dynamic threshold adjustments. Extensive experimentation demonstrates the effectiveness of our methods, achieving outstanding accuracy (93.28%), F1-score (82.05%), and AUC (96.41%) for classification tasks, and exceptional segmentation performance indicated by a Dice coefficient of 0.9091. The online platform significantly improved the accuracy, efficiency, and accessibility of clinical bladder cancer diagnostics, enabling practical and user-friendly deployment. The code is publicly available. Our multi-task framework and integrated online tool collectively advance the field of intelligent bladder cancer diagnosis by improving clinical reliability, supporting early tumor detection, and enabling real-time diagnostic feedback. These contributions mark a significant step toward AI-assisted decision-making in urology.

The use of Convolutional Neural Networks (CNNs) has greatly improved the interpretation of medical images. However, conventional CNNs typically demand extensive computational resources and large training datasets. To address these limitations, this study applied transfer learning to achieve strong classification performance using fewer training samples. Specifically, the study compared EfficientNetV2 with its predecessor, EfficientNet, and with ResNet50 in classifying brain tumors into three types: glioma, meningioma, and pituitary tumors. Results showed that EfficientNetV2 delivered superior performance compared to the other models. However, this improvement came at the cost of increased training time, likely due to the model's greater complexity.

The framework is designed to improve performance in the analysis of combined as well as single anatomical perspectives for MRI disease diagnosis. It specifically addresses the performance degradation observed in state-of-the-art (SOTA) models, particularly when processing axial, coronal, and sagittal anatomical planes. The paper introduces the FOLC-Net framework, which incorporates a novel federated-optimized lightweight architecture with approximately 1.217 million parameters and a storage requirement of only 0.9 MB. FOLC-Net integrates Manta-ray foraging optimization (MRFO) mechanisms for efficient model structure generation, global model cloning for scalable training, and ConvNeXt for enhanced client adaptability. The model was evaluated on combined multi-view data as well as individual views, such as axial, coronal, and sagittal, to assess its robustness in various medical imaging scenarios. Moreover, FOLC-Net tests a ShallowFed model on different data to evaluate its ability to generalize beyond the training dataset. The results show that FOLC-Net outperforms existing models, particularly in the challenging sagittal view. For instance, FOLC-Net achieved an accuracy of 92.44% on the sagittal view, significantly higher than the 88.37% accuracy of study method (DL + Residual Learning) and 88.95% of DL models. Additionally, FOLC-Net demonstrated improved accuracy across all individual views, providing a more reliable and robust solution for medical image analysis in decentralized environments. FOLC-Net addresses the limitations of existing SOTA models by providing a framework that ensures better adaptability to individual views while maintaining strong performance in multi-view settings. The incorporation of MRFO, global model cloning, and ConvNeXt ensures that FOLC-Net performs better in real-world medical applications.

We propose HQCM-EBTC, a hybrid quantum-classical model for automated brain tumor classification using MRI images. Trained on a dataset of 7,576 scans covering normal, meningioma, glioma, and pituitary classes, HQCM-EBTC integrates a 5-qubit, depth-2 quantum layer with 5 parallel circuits, optimized via AdamW and a composite loss blending cross-entropy and attention consistency. HQCM-EBTC achieves 96.48% accuracy, substantially outperforming the classical baseline (86.72%). It delivers higher precision and F1-scores, especially for glioma detection. t-SNE projections reveal enhanced feature separability in quantum space, and confusion matrices show lower misclassification. Attention map analysis (Jaccard Index) confirms more accurate and focused tumor localization at high-confidence thresholds. These results highlight the promise of quantum-enhanced models in medical imaging, advancing both diagnostic accuracy and interpretability for clinical brain tumor assessment.

This study presents a convolutional neural network (CNN)-based approach for the multi-class classification of brain tumors using magnetic resonance imaging (MRI) scans. We utilize a publicly available dataset containing MRI images categorized into four classes: glioma, meningioma, pituitary tumor, and no tumor. Our primary objective is to build a light weight deep learning model that can automatically classify brain tumor types with high accuracy. To achieve this goal, we incorporate image preprocessing steps, including normalization, data augmentation, and a cropping technique designed to reduce background noise and emphasize relevant regions. The CNN architecture is optimized through hyperparameter tuning using Keras Tuner, enabling systematic exploration of network parameters. To ensure reliable evaluation, we apply 5-fold cross-validation, where each hyperparameter configuration is evaluated across multiple data splits to mitigate overfitting. Experimental results demonstrate that the proposed model achieves a classification accuracy of 98.78%, indicating its potential as a diagnostic aid in clinical settings. The proposed method offers a low-complexity yet effective solution for assisting in early brain tumor diagnosis.

Glioma, the prevalent primary brain tumor, exhibits diverse aggressiveness levels and prognoses. Precise classification of glioma is paramount for treatment planning and predicting prognosis. This study aims to develop an algorithm to fuse the MRI images from T1, T2, T1ce, and fluid-attenuated inversion recovery (FLAIR) sequences to enhance the efficacy of glioma subclass classification as no tumor, necrotic core, peritumoral edema, and enhancing tumor. The MRI images from BraTS datasets were used in this work. The images were pre-processed using max-min normalization to ensure consistency in pixel intensity values across different images. The segmentation of the necrotic core, peritumoral edema, and enhancing tumor was performed on 2D and 3D images separately using UNET architecture. Further, the segmented regions from multimodal MRI images were fused using the weighted averaging technique. Integrating 2D and 3D segmented outputs enhances classification accuracy by capturing detailed features like tumor shape, boundaries, and intensity distribution in slices, while also providing a comprehensive view of spatial extent, shape, texture, and localization within the brain volume. The fused images were used as input to the pre-trained ResNet50 model for glioma subclass classification. The network is trained on 80% and validated on 20% of the data. The proposed method achieved a classification of accuracy of 99.25%, precision of 99.30%, recall of 99.10, F1 score of 99.19%, Intersection Over Union of 84.49%, and specificity of 99.76, which showed a significantly higher performance than existing techniques. These findings emphasize the significance of glioma segmentation and classification in aiding accurate diagnosis.